Last updated: February 19, 2026
The Technetium Tc-99m Pentetate Kit, used in nuclear medicine imaging, is supplied by several manufacturers globally, primarily those registered with the U.S. Food and Drug Administration (FDA) or corresponding authorities in other regions. The availability of these kits depends on regional regulatory approvals and distribution channels.
Key Suppliers
| Supplier |
Product Name |
Regulatory Status |
Geographic Distribution |
Notes |
| Bracco Diagnostics Inc. |
Cardiolite (approved in some regions) |
FDA-approved (U.S.) |
U.S., select international markets |
Similar kits; availability varies by market |
| Curium Pharma (formerly IBA Molecular) |
TechneScan® SPECT |
CE Mark (Europe) / FDA approvals |
Europe, Australia, parts of Asia |
Supplies Tc-99m kits including Pentetate |
| Melbourne-based Institute of Nuclear Medicine & Allied Sciences (INMAS) |
Tc-99m Pentetate kits |
Regional manufacturing |
India |
Typically for local distribution |
| Shenzhen Forerise Technologies |
Tc-99m Pentetate Kits |
Regulatory approvals vary |
China |
Distributes within China |
| COVIDIEN (Medtronic) |
Tc-99m Pentetate Kits |
Previously available (market changes) |
International markets |
Integration into Medtronic product lines |
Regulatory and Market Notes
- U.S. Market: The predominant supplier is GE Healthcare with their TechneCam™ suite, though other suppliers like Bracco and selected regional vendors provide equivalent products. Suppliers must hold FDA approval for their kits.
- European Market: CE-marked kits are available through several vendors including Curium Pharma. In Europe, regulatory pathways include the CE mark rather than FDA approval.
- Asia and Other Regions: China and India have local suppliers manufacturing Tc-99m kits. Regulatory approval varies per country; local distribution channels are common.
Regulatory Considerations
- The FDA approval process for Tc-99m kits involves demonstrating safety, efficacy, and manufacturing quality.
- Regional approval agencies (e.g., European Medicines Agency) assess similar criteria with regional adaptations.
- Manufacturers must adhere to the guidelines set by the International Atomic Energy Agency (IAEA) for handling and distribution.
Distribution and Procurement Channels
- Typical procurement involves direct contracts with manufacturers or authorized distributors.
- International suppliers often participate in tenders through government or hospital procurement processes.
- Some regional suppliers may not have FDA approval but are licensed locally, especially in markets with less stringent regulation.
Availability and Market Trends
- The global Tc-99m generator and kit market is dominated by a few key players, with an increasing focus on supply chain stability due to aging nuclear medicine infrastructure.
- Recent shortages in molybdenum-99 (the parent isotope of Tc-99m) affect kit availability globally.
- Manufacturers are investing in alternative production methods, such as cyclotron-produced Tc-99m, to mitigate supply risks.
Summary
The primary suppliers of the Technetium Tc-99m Pentetate Kit include Bracco Diagnostics Inc., Curium Pharma, and regional manufacturers in Asia. Availability depends on regional regulatory approvals, with FDA and CE marking indicating market access. Procurement is conducted through authorized distributors, with supply chain stability influenced by molybdenum-99 availability and nuclear medicine infrastructure.
Key Takeaways
- Major suppliers: Bracco (U.S. and international markets), Curium Pharma (Europe, Australia), regional manufacturers in Asia.
- Regulatory status: FDA approval and CE marking are pivotal for market access.
- Market challenges: Supply chain shortages due to molybdenum-99 scarcity.
- Procurement typically involves direct or distributor channels.
- Regional manufacturing adapts to local regulatory frameworks, affecting product availability.
FAQs
-
Which companies are authorized to supply Tc-99m Pentetate Kits in the U.S.?
Bracco Diagnostics and GE Healthcare are major authorized suppliers, both holding FDA approval.
-
Are Tc-99m Pentetate Kits available outside North America?
Yes. Curium Pharma supplies CE-marked kits in Europe and Australia. Regional providers operate in Asia.
-
What factors influence the availability of these kits globally?
Regulatory approvals, supply chain stability (particularly molybdenum-99 shortages), and regional manufacturing capacity.
-
Can alternative isotopes or kits replace Tc-99m Pentetate?
Alternatives exist but are not identical. Tc-99m remains the standard due to its optimal physical properties for imaging.
-
How do supply shortages impact clinical practice?
Shortages can delay diagnosis and treatment, prompting reliance on alternative diagnostic modalities or regional supply sources.
References
[1] U.S. Food and Drug Administration. (2022). Regulatory status of radiopharmaceuticals. FDA.gov.
[2] European Medicines Agency. (2022). Regulatory framework for radiopharmaceuticals. EMA.europa.eu.
[3] International Atomic Energy Agency. (2020). Guidelines for production and quality control of molybdenum-99 and technetium-99m radiopharmaceuticals. IAEA.org.
